There is an urgent need to discover novel antibiotics, particularly with activity against Gram-negative bacteria that are the most threatening for public health. In the past, nature has been the main source of antibiotic ...

The oligopeptides cystobactamid and Myxovalargin A are natural products produced by myxobacteria. Both secondary metabolites exhibit high antibacterial activity and are currently in different stages of preclinical antibiotic ...

Bacterial resistance is omnipresent and expected to be a future problem as warned by the World Health Organization (WHO) reports and guidelines since 2014,[1-3] Centers for Disease Control and Prevention (CDC)[4] ...